NEW YORK, NY / ACCESSWIRE / December 10, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Rexnord Corp (NYSE: RXN), NOW Inc (NYSE: DNOW), Vanda Pharmaceuticals Inc (NASDAQ: VNDA) and Inovalon Holdings Inc (NASDAQ: INOV). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
RXN Research Package: http://www.traders-choice.com/pdf?s=RXN
DNOW Research Package: http://www.traders-choice.com/pdf?s=DNOW
VNDA Research Package: http://www.traders-choice.com/pdf?s=VNDA
INOV Research Package: http://www.traders-choice.com/pdf?s=INOV
Highlights from today's reports include:
On Wednesday, December 09, 2015, Nasdaq ended at 5,022.87 down 1.48%, Dow Jones declined 0.43%, to finish the day at 17,492.30, and the S&P closed at 2,047.62, down 0.77%.
- The stock of Rexnord Corp lost 0.65% to close Wednesday's session at USD 18.48. The shares of the company moved in the range of USD 18.35 and USD 18.91. A trading volume of 0.91 million shares was recorded, which was greater than its 150-day daily average volume of 0.71 million shares and above its 52-week average volume of 0.66 million shares. Over the last five days, Rexnord Corp's shares have declined by 8.29% and in the past one month, it has lost 8.92%. Further, the company is trading at a price to earnings ratio of 24.64 which compares to a historical PE ratio of 30.45. The price to sales ratio is 0.94 and the price to book ratio is 3.43. Additionally, the stock is trading below the 50-day moving average of USD 19.44 and below the 200-day moving average of USD 20.99.
- NOW Inc's stock increased by 1.19% to close Wednesday's session at USD 16.96. The company's shares fluctuated in the range of USD 16.80 and USD 17.47. A total of 1.00 million shares exchanged hands, which was lesser than its 50-day daily average volume of 1.24 million shares and was below its 52-week average volume of 1.27 million shares. Over the last three days, NOW Inc's shares have declined by 6.81% and in the past one week it has moved down 7.37%. The stock has yielded a return of 3.29% in the past three months, on a compounded total return basis. In addition to this, the stock is trading below both the 50-day moving average and 200-day moving average of USD 17.44 and USD 18.25, respectively. Further, the company is trading at price to sales ratio is 0.53 and the price to book ratio is 1.08.
- Vanda Pharmaceuticals Inc's stock added 7.88% to close Wednesday's session at USD 8.83. The company's shares oscillated between USD 8.00 and USD 9.01, marking a new 52-week low during the session. The stock recorded a trading volume of 1.81 million shares, which was above its 50-day daily average volume of 0.77 million shares and above its 52-week average volume of 0.81 million shares. Over the last five days, Vanda Pharmaceuticals Inc's shares have declined by 9.25% and in the past one month, it has lost 9.62%. Further, the company is trading at a price to earnings ratio of 7.48 and the stock is at a price to book ratio of 2.40. This compares to a historical PE ratio of 26.03. The historical PB ratio is near to 3.69. Additionally, the stock is trading at a price to sales ratio of 3.75.
- Inovalon Holdings Inc's stock advanced 1.79% to close Wednesday's session at USD 19.94. The share price vacillated between USD 19.43 and USD 20.09. The stock recorded a trading volume of 0.80 million shares, which was above its 50-day daily average volume of 0.44 million shares and above its 52-week average volume of 0.59 million shares. Over the last three days, Inovalon Holdings Inc's shares have advanced 6.29% and in the past one week it has moved up 9.20%. While, in the last six months, the stock has lost 28.91%. Moreover, the company's shares are trading at par with the 50-day moving average of USD 19.93 but below the 200-day moving average of USD 23.07. In addition to this, the stock of Inovalon Holding Inc is at a price to sales ratio of 7.27 and price to book ratio of 4.12.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice